GIP
Glucose-dependent insulinotropic polypeptide · Gastric inhibitory polypeptide
One of the two main incretin hormones, released from the gut after eating and acting at the GIP receptor. It is the second target that dual agonists such as tirzepatide combine with GLP-1, which is why it appears in discussion of that class. An endogenous hormone, not a marketed product on its own.
Tracking and educational reference only, on values you enter yourself. Not medical advice or a dosing recommendation.
Half-life
Minutes in circulation, being rapidly inactivated by DPP-4. Half-life is an educational pharmacology figure, drawn from public sources, and is not a schedule or dosing instruction.
Storage & handling
No approved label defines handling.
References
- Molecular Metabolism 2025: glucose-dependent insulinotropic polypeptide (GIP), a review
Read the source
Related in GLP-1 / Metabolic
Educational reference only, compiled from public sources. Not medical advice, diagnosis, treatment, or a dosing recommendation, and not a recommendation to use any compound. Many compounds listed are research materials not approved for human use. Consult a qualified professional.